Infection treatment guided by advanced testing after liver transplant
Part of Infections clinical trials.
This trial tests whether using a sensitive DNA test (mNGS) to find the exact cause of an infection leads to better treatment for liver transplant recipients who got an infection from their donor.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older
- You have had a liver transplant
- The person who donated your liver had an infection and was treated for it
- You have complete medical records for both yourself and your donor
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a blood test that looks for infection by analyzing tiny bits of DNA from microbes. It may help find infections faster in people with weakened immune systems, such as transplant recipients or those with blood cancers.
This trial uses a new DNA-sequencing method, nanopore adaptive sequencing, to monitor liver transplant patients. It aims to see if this technology can better track their health after transplant.
This trial uses a DNA test to better detect infections in people with advanced liver disease who are hospitalized. It may help doctors find the right treatment faster.
This study looks at what germs cause infections in people who have had a liver transplant. It aims to help doctors better prevent and treat infections after transplant.
This trial checks if monitoring antibiotic levels in the blood can help doctors give the right dose to liver transplant patients with serious bacterial infections. The goal is to make the treatment work better.
This study develops a tool to predict which liver transplant patients might develop infections after surgery. By identifying high-risk patients early, doctors could provide extra monitoring or preventive care to improve outcomes.
Hear when a new Infection trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.